Physician profile
Marc A Singer
NPI 1932289584
$10,375.39
in general payments reported to CMS, 2019-2025
36 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,060 · 2020: $1,567 · 2021: $1,308 · 2022: $1,508 · 2023: $1,716 · 2024: $1,192 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.16 |
| Travel and Lodging | $297.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,190.69 | 2019-2025 | Eliquis, Cobenfy, Camzyos |
| Janssen Pharmaceuticals, INC | $1,100.32 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $876.04 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novartis Pharmaceuticals Corporation | $851.25 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $769.35 | 2019-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Amgen INC. | $767.79 | 2019-2025 | Repatha, Repatha, Prolia |
| Pfizer INC. | $727.30 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $580.78 | 2019-2023 | Jardiance, Ofev |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $498.79 | 2019-2025 | Xifaxan, Trulance |
| Stryker Corporation | $489.43 | 2019 | |
| Novo Nordisk INC | $347.24 | 2021-2025 | Ozempic, Rybelsus |
| Intuitive Surgical, INC. | $297.33 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $185.78 | 2021-2024 | Vraylar, Viberzi, Linzess |
| Allergan, INC. | $185.50 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $183.89 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $166.86 | 2019-2023 | Jot Dx |
| Lilly USA, LLC | $155.88 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Scpharmaceuticals INC. | $155.57 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $125.32 | 2019-2023 | Evkeeza |
| Sanofi Pasteur INC. | $100.50 | 2019-2024 | |
| Heartflow, INC. | $100.50 | 2024-2025 | |
| Exact Sciences Corporation | $93.16 | 2024 | Cologuard Collection Kit |
| Insulet Corporation | $67.83 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $46.02 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $42.36 | 2024 | Assure Wcd |
| Renalytix Ai, INC. | $38.80 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Biotronik INC. | $37.88 | 2019 | |
| Philips North America LLC | $35.27 | 2024 | (Ck4) Mcot |
| Astellas Pharma US INC | $25.61 | 2024 | Veozah |
| Lexicon Pharmaceuticals, INC. | $22.89 | 2023 | Inpefa |
| Amarin Pharma, INC. | $22.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.45 | 2019 | |
| Boston Scientific Corporation | $21.14 | 2019 | |
| Daiichi Sankyo INC. | $15.39 | 2022 | |
| Intuity Medical INC | $14.61 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Glaxosmithkline, LLC. | $14.54 | 2023 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.